TipRanks
Alterity Therapeutics (PRNAF)
OTHER OTC:PRNAF

Compare Alterity Therapeutics (PRNAF) vs. Competitors

7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alterity Therapeutics
$0.40
$42.68M
-2.40
-64.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Actinogen Medical
AU$0.04
AU$162.72M
-8.75
23.53%
1 Buy
0 Hold
0 Sell
Moderate Buy
Cynata Therapeutics Limited
AU$0.01
AU$4.02M
-0.31
-94.98%
―
Tryptamine Therapeutics
AU$0.04
AU$50.66M
-13.48
-16.22%
―
Living Cell Technologies
AU$0.01
AU$20.28M
-5.71
0.00%
―
Neuren Pharmaceuticals Limited
AU$20.45
AU$2.58B
128.62
-7.20%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRNAF
Alterity Therapeutics
0.25
-0.29
-53.70%
AU:ACW
Actinogen Medical
0.04
<0.01
20.00%
AU:CYP
Cynata Therapeutics Limited
0.01
-0.23
-94.98%
AU:ENP
Tryptamine Therapeutics
0.03
>-0.01
-18.42%
AU:1AI
Living Cell Technologies
0.01
0.00
0.00%
AU:NEU
Neuren Pharmaceuticals Limited
20.36
-1.24
-5.75%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts